Janus Henderson Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Sell |
49,564
-1,007,582
| -95% | -$33.3M | ﹤0.01% | 1382 |
|
|
2025
Q1 | $45.7M | Buy |
1,057,146
+32,729
| +3% | +$1.41M | 0.03% | 396 |
|
|
2024
Q4 | $48.2M | Sell |
1,024,417
-119,413
| -10% | -$5.62M | 0.02% | 397 |
|
|
2024
Q3 | $60.4M | Buy |
1,143,830
+167,501
| +17% | +$8.84M | 0.03% | 346 |
|
|
2024
Q2 | $52.9M | Buy |
976,329
+178,957
| +22% | +$9.7M | 0.03% | 368 |
|
|
2024
Q1 | $55.9M | Sell |
797,372
-1,771,033
| -69% | -$124M | 0.03% | 370 |
|
|
2023
Q4 | $214M | Buy |
2,568,405
+75,079
| +3% | +$6.27M | 0.13% | 173 |
|
|
2023
Q3 | $73.5M | Buy |
2,493,326
+397,627
| +19% | +$11.7M | 0.05% | 286 |
|
|
2023
Q2 | $68.4M | Buy |
2,095,699
+522,055
| +33% | +$17M | 0.04% | 329 |
|
|
2023
Q1 | $55.4M | Buy |
1,573,644
+1,399,714
| +805% | +$49.3M | 0.04% | 361 |
|
|
2022
Q4 | $7.97M | Buy |
173,930
+144,004
| +481% | +$6.6M | 0.01% | 766 |
|
|
2022
Q3 | $1.45M | Buy |
29,926
+14,984
| +100% | +$726K | ﹤0.01% | 1458 |
|
|
2022
Q2 | $587K | Sell |
14,942
-6
| -0% | -$236 | ﹤0.01% | 1669 |
|
|
2022
Q1 | $550K | Buy |
14,948
+4
| +0% | +$147 | ﹤0.01% | 1850 |
|
|
2021
Q4 | $682K | Buy |
14,944
+7,528
| +102% | +$344K | ﹤0.01% | 1694 |
|
|
2021
Q3 | $265K | Buy |
+7,416
| New | +$265K | ﹤0.01% | 1956 |
|
|
2017
Q4 | – | Sell |
-2,778,605
| Closed | -$40.3M | – | 1313 |
|
|
2017
Q3 | $40.3M | Buy |
2,778,605
+93,675
| +3% | +$1.36M | 0.03% | 573 |
|
|
2017
Q2 | $32.5M | Buy |
+2,684,930
| New | +$32.5M | 0.02% | 630 |
|